Krishna Institute of Medical Sciences Ltd Q4 FY25 Results

Summary

Krishna Institute of Medical Sciences Ltd (KIMS Hospitals) announced its audited (Standalone & Consolidated) financial results for the quarter and financial year ended 31* March 2025. The company reported a total revenue of INR 801 Cr in Q4 FY25, a growth of 25.7% on YoY and 1.4% on QoQ basis. The EBITDA for the same period was INR 203 Cr, a growth of 24.4% on YoY and a de growth of 1.2% on QoQ basis. The EBITDA margin stood at 25.3%. The PAT for Q4 FY25 was INR 106 Cr. The consolidated EPS for FY25 was INR 9.6, a growth of 24.0% on YoY basis. The cash and cash equivalents as on Q4 FY25 were INR 102 Cr.

Key Highlights

1. 1

   Q4 FY25 total revenue of INR 801 Cr, a growth of 25.7% YoY and 1.4% QoQ

2. 2

   Q4 FY25 EBITDA of INR 203 Cr, a growth of 24.4% YoY and de growth of 1.2% QoQ

3. 3

   FY25 total revenue of INR 3,067 Cr, a growth of 22.0% YoY

4. 4

   FY25 EBITDA of INR 815 Cr, a growth of 24.7% YoY

5. 5

   FY25 PAT of INR 415 Cr, a growth of 24.0% YoY

6. 6

   Consolidated EPS for FY25 of INR 9.6, a growth of 24.0% on YoY basis

7. 7

   Cash and Cash Equivalents as on Q4 FY25 of INR 102 Cr